Ezra Hahn

Princess Margaret Cancer Centre

Papers

1

Total Citations

21

H-Index

1

About

Ezra Hahn is a pioneering urologic surgeon whose work centers on the application of robotic surgery to complex oncologic cases, particularly testicular cancer. His major contribution is the advancement of robotic retroperitoneal lymph node dissection (R-RPLND), a minimally invasive technique that reduces morbidity while maintaining oncologic rigor. His landmark 2021 paper, "Robotic retroperitoneal lymph node dissection for primary and post-chemotherapy testis cancer," has garnered 21 citations, establishing a foundational protocol for both primary and post-chemotherapy settings. This work demonstrates that robotic approaches can achieve equivalent nodal clearance to open surgery with faster recovery and less blood loss—a critical advance for young patients facing lifelong survivorship. Beyond this, Hahn has been instrumental in refining patient selection criteria and standardizing the technical steps of R-RPLND, helping to expand its adoption in high-volume centers. His research bridges the gap between surgical innovation and evidence-based practice, offering a compelling alternative to traditional open surgery. For trainees and researchers, Hahn’s work exemplifies how thoughtful integration of technology can transform outcomes in genitourinary oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
21
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Robotic retroperitoneal lymph node dissection for primary and post-chemotherapy testis cancer
21 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Princess Margaret Cancer Centre

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago